Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Tue Apr 01 16:29:33 GMT 2025
by
admin
on
Tue Apr 01 16:29:33 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | VIRUS |
| Source Materials Parent | |
| Part | polymerase |
| Record UNII |
A3Z87NSO0U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
A3Z87NSO0U
Created by
admin on Tue Apr 01 16:29:33 GMT 2025 , Edited by admin on Tue Apr 01 16:29:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR->TARGET ORGANISM |
Delavirdine has demonstrated an IC50 of 0.26 micromolar against recombinant reverse transcriptase; at 3 micromolar, it halted the spread of virus in MT-4 cells and blocked replication of primary HIV-1 isolates in peripheral blood lymphocytes, including zidovudine-resistant variants.
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
IC50
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Unique mode of action byblocking primer translocation without causing direct chain termination.
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR->TARGET ORGANISM |
Non-nucleoside inhibitor
|
||
|
INHIBITOR -> TARGET |
Emtricitabine 5'-triphosphate inhibits the activity of the HIV-1 reverse transcriptase by competing with the natural substrate deoxycytidine 5'-triphosphate and by being incorporated into nascent viral DNA which results in chain termination.
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
NNRTI
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Non-nucleoside RT inhibitor
|
||
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
HIV-1 nucleoside reverse transcriptase translocation inhibitor
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |